Group tasks 2

Continuous surveillance of needs and opportunities and development criteria

• GT Leader: IRB Barcelona, Partner 1
• Other participants: USC, INSERM, IBMC, PCB, BIOCANT
• Start date: April 2009
• End date: March 2012
• Actions:
  • Continous surveillance
  • Development of criteria
• Deliverables:
  • Report on criteria for the development of miniaturized methods: month 12, USC
  • Report on continuous surveillance for drug development, month 24, IRB-PCB
  • Report on criteria for drug development for the treatment of metabolic diseases, month 36, IRB-INSERM